Augmentation of interleukin 1 and interleukin 2 production by OK-432

International Journal of Immunopharmacology

Volumn 7, Issue 2, 1985, Pages 263-270

  Osamu Ichimura, ^a   Seikichi Suzuki, ^a   Motoo Saito, ^a   Yutaka Sugawara, ^a   Nakao Ishida, ^a  

^a CHUGAI PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CONCANAVALIN A; INTERLEUKIN 1; INTERLEUKIN 2; LYMPHOKINE; PICIBANIL;

ANIMAL EXPERIMENT; BLOOD AND HEMOPOIETIC SYSTEM; DRUG EFFICACY; HEMOLYTIC STREPTOCOCCUS; IN VITRO STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PERITONEUM; PERITONEUM CELL; PRIORITY JOURNAL; RETICULOENDOTHELIAL SYSTEM;

ANIMALS; ASCITIC FLUID; BIOLOGICAL PRODUCTS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; INTERLEUKIN-1; INTERLEUKIN-2; MICE; MICE, INBRED BALB C; PICIBANIL;

EID: 0021881750     PISSN: 01920561     EISSN: None     Source Type: Journal    
DOI: 10.1016/0192-0561(85)90035-9     Document Type: Article

References (17)

1. The biochemistry, biology, and role of interleukin 2 in the induction of cytotoxic T cells and antibody-forming B cell responses
2. Thymoma production of T cell growth factor (interleukin 2)
3. Characterization of mitogenic factors and their effect on the antibody response in vitro
4. Evidence for in vivo protection against murine-sarcoma virus-induced tumors by T lymphocytes from immune animals
5. Cytotoxic cells induced in tumor bearing rats by a streptococcal preparation OK-432
6. New approach to management of malignant ascites with a streptococcal prepararation, OK-432. II. Intraperitoneal inflammation cell-mediated tumor cell destruction
7. Activation of macrophage function by intraperitoneal administration of the streptococcal antitumor agent OK-432
8. Induction of immune interferon in mice treated with a bacterial immunopotentiator OK-432
9. Interleukin 1 and T cell activation
10. Characterization of lymphocyte-activating factor (LAF) produced by macrophage cell line P388D1. I. Enhancement of LAF production by activated T-lymphocytes
11. Induction of interferon-γ in mouse spleen cells by OK-432, a preparation of Streptococcus pyogenes
12. In vitro production of interferon (IFN) by murine spleen cells when different sensitizing agents are used in vivo and in vitro
13. Role of different T cell sets in the rejection of syngeneic chemically induced tumors
14. New approach to management of malignant ascites with a streptococcal preparation, OK-432. I. Improvement of host immunity and prolongation of survival
15. Clinical studies on cell-mediated immunity in patients with malignant diseases; I. Effect of immunotherapy with OK-432 on lymphocyte subpopulation and phytomitogen responsiveness in in vitro
16. Biochemical and biological characterization of lymphocyte regulating molecules. I. Purification of a class of murine lymphokines
17. Purification of human interleukin 2 to apparent homogeneity and its molecular heterogeniety